A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort&#174; 160/4.5 in Healthy Volunteers Without Charcoal Block

modified-release formulation of lovastatin lactone (SYN-010) - Synthetic Biologics

budesonide/formotenol (SYN010) - Intech Biopharm

Symbicort (budesonide/formoterol) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT04494321

Aug 7, 2020